0001209191-21-008499.txt : 20210208 0001209191-21-008499.hdr.sgml : 20210208 20210208164837 ACCESSION NUMBER: 0001209191-21-008499 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210205 FILED AS OF DATE: 20210208 DATE AS OF CHANGE: 20210208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lebowitz Joel CENTRAL INDEX KEY: 0001797829 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39206 FILM NUMBER: 21602064 MAIL ADDRESS: STREET 1: SCHRODINGER, INC. STREET 2: 120 WEST 45TH STREET, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Schrodinger, Inc. CENTRAL INDEX KEY: 0001490978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 954284541 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 503-299-1150 MAIL ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-05 0 0001490978 Schrodinger, Inc. SDGR 0001797829 Lebowitz Joel C/O SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR NEW YORK NY 10036 0 1 0 0 EVP & CFO Common Stock 2021-02-05 4 M 0 12374 17.00 A 12374 D Common Stock 2021-02-05 4 S 0 900 97.9025 D 11474 D Common Stock 2021-02-05 4 S 0 10359 99.1809 D 1115 D Common Stock 2021-02-05 4 P 0 1115 99.8977 D 0 D Stock Option (right to buy) 17.00 2021-02-05 4 M 0 12374 0.00 D 2030-02-05 Common Stock 12374 37122 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.56 to $98.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) of this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.57 to $99.56, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.60 to $100.20, inclusive. This option was granted on February 5, 2020. The shares underlying the option vested with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024. /s/ Donald Shum, as attorney-in-fact for Joel Lebowitz 2021-02-08